Release Date: 31/10/18 09:07 Summary: Quarterly Cashflow Report Price Sensitive: Yes Download Document 270.75KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%